In breast and colon cancer, VitD increased dose dependently the expression of the extracellular canonical Wnt inhibitor, DKK-1, that is associated with growth inhibition, showing a protective role of VitD against breast cancer development, progression, and metastasis [51]. Here, DKK1 is linked to malignant colon neoplasm.